News list last updated on 30/01/2025
25 news

Events
Published on 30/01/2025
Hematology Days 2025
We would like to inform you that the 2025 Haematology Days will be held on 13 March, 17 April and 15 May for the staff of the hematology department of the Lyon Sud Hospital.
This unique event will gather experts, health professionals and researchers to discuss this year the theme of clinical research .
Read more

Fundamental research
Published on 30/01/2025
The ImmuneT-ME: Interrogation of the immune-microenvironment of T-cell malignancies project winner of the European EP PerMed 2024 call for projects
The Inserm LIB research team led by Prof. Emmanuel Bachy is the winner of this European call for proposals for the development of new treatments of peripheral T-cell lymphomas.
With a total funding of nearly €2 million for the European consortium, including €300,000 directly allocated to the Lyon research team, the objective is to discover new therapeutic targets based on a detailed analysis of the tumor microenvironment in this type of lymphoma, whose prognosis remains particularly poor.

Fundamental research
Published on 20/12/2024
A grant of €640,500 from the Ligue Contre le Cancer for Prof. BACHY’s Team: Towards a New Approach to CAR T Cells
In response to the 2024 call for proposals of the Ligue Contre le Cancer "Innovative cell therapies in oncology: new vectors, new targets", Prof. Emmanuel BACHY's team has obtained a grant of € 640,500 for the project "Functional improvement of CAR-T cells by Boolean and epigenetic approaches".
This 3-year project is being carried out in collaboration with Prof. Olivier Hermine, Head of the Hematology Department at Necker Hospital and Director of Inserm Unit U1163 at the Imagine Institute in Paris, Prof. Michel Sadelain, Head of the Center for Cell Engineering at Memorial Sloan Kettering Cancer (MSKCC) in New York and Dr. Laurent Genestier, co-director of the Lymphoma Immunobiology team in Lyon (LIB) Inserm U1111-CNRS UMR 5308.

Events
Published on 07/01/2025
Regional Post-ASH Day
We are pleased to inform you of the organization of the Regional Post ASH Day, which will be held on March 21, 2025 at the Lyon Sud University Hospital.
This event is a unique opportunity to share scientific information and news on the latest advances in the field of hematology (allografts, AML and ALL, myelodysplastic syndromes, lymphomas, benign haematology, PNH, aplasia and myeloproliferative syndromes, multiple myeloma and CLL).
We hope to see many of you for this event that brings together the hematological community of the region.

Clinical trials
Published on 01/01/2025
Patient-reported outcomes following ciltacabtagene autoleucel or standard of care in patients with lenalidomide-refractory multiple myeloma (CARTITUDE-4): results from a randomised, open-label, phase 3 trial.
Mina R, Mylin AK, Yokoyama H, Magen H, Alsdorf W, Minnema MC, Shune L, Isufi I, Harrison SJ, Shah UA, Schecter JM, Vogel M, Lendvai N, Gries KS, Katz EG, Slaughter A, Lonardi C, Gilbert J, Li Q, Deraedt W, Filho OC, Patel N, Florendo E, Karlin L, Weisel K
Read more
Events
Published on 07/12/2024
Dr Maël Heiblig in the spotlight: oral participation at ASH 2024
Session: 615. Acute Myeloid Leukemias: Clinical and Epidemiology: Genetic Markers and Outcomes in AML
Read more

Clinical trials
Published on 16/02/2024
Romidepsin Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Versus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Patients With Previously Untreated Peripheral T-Cell Lymphoma: Final Analysis of the Ro-CHOP Trial
Vincent Camus, Catherine Thieblemont, Philippe Gaulard, Morgane Cheminant, Rene-Olivier Casasnovas, Loïc Ysebaert, Gandhi Laurent Damaj, Stéphanie Guidez, Gian Matteo Pica, Won Seog Kim, Soon Thye Lim, Marc Andre, Norma Gutiérrez, Maria Jesus Penarrubia, Philipp B Staber, Judith Trotman, Andreas Hüttmann, Vittorio Stefoni, Alessandra Tucci, Patrick Fogarty, Hassan Farh, Julie Abraham, Wajed Abarah, Fatiha Belmecheri, Vincent Ribrag, Marie-Helene Delfau-Larue, Anne-Ségolène Cottereau, Emmanuel Itti, Ju Li, Richard Delarue, Laurence de Leval, Franck Morschhauser, Emmanuel Bachy
Read more

Clinical trials
Published on 14/03/2024
The phase 2 LYSA study of prednisone, vinblastine, doxorubicin, and bendamustine for untreated Hodgkin lymphoma in older patients
Hervé Ghesquières, Daphné Krzisch, Emmanuelle Nicolas-Virelizier, Salim Kanoun, Anne Claire Gac, Stéphanie Guidez, Mohamed Touati, Kamel Laribi, Franck Morschhauser, Christophe Bonnet, Agathe Waultier-Rascalou, Frédérique Orsini-Piocelle, Marc André, Marguerite Fournier, Fabienne Morand, Alina Berriolo-Riedinger, Barbara Burroni, Diane Damotte, Alexandra Traverse-Glehen, Philippe Quittet, Olivier Casasnovas
Read more